Huperzine A Activates Wnt/β-Catenin Signaling and Enhances the Nonamyloidogenic Pathway in an Alzheimer Transgenic Mouse Model

Autor: Bao-Lu Zhao, Zhan-You Wang, Jing-Wei Xie, Chun-Yan Wang, Si-Ling Wang, Wei-Ping Teng, Tao Wang, Wei Zheng
Rok vydání: 2011
Předmět:
Male
ADAM10
Pharmacology
Amyloid beta-Protein Precursor
Mice
Neuroblastoma
chemistry.chemical_compound
GSK-3
Blood-Retinal Barrier
Enzyme Inhibitors
beta Catenin
Huperzine A
Microscopy
Confocal

Wnt signaling pathway
Olfactory Bulb
Acetylcholinesterase
Psychiatry and Mental health
Original Article
Sesquiterpenes
Signal Transduction
medicine.drug
Genetically modified mouse
Beta-catenin
Cell Survival
Neurogenesis
Enzyme-Linked Immunosorbent Assay
Mice
Transgenic

Nerve Tissue Proteins
Biology
Transfection
Neuroprotection
Alkaloids
Alzheimer Disease
Presenilin-1
medicine
Animals
Humans
RNA
Messenger

Analysis of Variance
Amyloid beta-Peptides
Molecular biology
Mice
Inbred C57BL

Wnt Proteins
Disease Models
Animal

Bromodeoxyuridine
Gene Expression Regulation
chemistry
Mutation
Microscopy
Electron
Scanning

biology.protein
Cholinesterase Inhibitors
Zdroj: Neuropsychopharmacology. 36:1073-1089
ISSN: 1740-634X
0893-133X
DOI: 10.1038/npp.2010.245
Popis: Huperzine A (HupA) is a reversible and selective inhibitor of acetylcholinesterase (AChE), and it has multiple targets when used for Alzheimer's disease (AD) therapy. In this study, we searched for new mechanisms by which HupA could activate Wnt signaling and reduce amyloidosis in AD brain. A nasal gel containing HupA was prepared. No obvious toxicity of intranasal administration of HupA was found in mice. HupA was administered intranasally to β-amyloid (Aβ) precursor protein and presenilin-1 double-transgenic mice for 4 months. We observed an increase in ADAM10 and a decrease in BACE1 and APP695 protein levels and, subsequently, a reduction in Aβ levels and Aβ burden were present in HupA-treated mouse brain, suggesting that HupA enhances the nonamyloidogenic APP cleavage pathway. Importantly, our results further showed that HupA inhibited GSK3α/β activity, and enhanced the β-catenin level in the transgenic mouse brain and in SH-SY5Y cells overexpressing Swedish mutation APP, suggesting that the neuroprotective effect of HupA is not related simply to its AChE inhibition and antioxidation, but also involves other mechanisms, including targeting of the Wnt/β-catenin signaling pathway in AD brain.
Databáze: OpenAIRE